Walmart Inc. filed a lawsuit against the federal government, seeking clarity on the roles and legal responsibilities of pharmacists and pharmacies in filling opioid prescriptions.
The U.S. government said pharmacists would be allowed to administer routine vaccines to children, calling a drop in immunization from lockdowns aimed at curbing the spread of the coronavirus a “public health threat.”
Dr. Reddy’s Laboratories Ltd. announced the launch of Trientine Hydrochloride Capsules USP, 250 mg, a therapeutically equivalent generic version of Syprine (trientine hydrochloride) Capsules, approved by the U.S. Food and Drug Administration for treating Wilson’s disease.
President Donald Trump signed a bill into law that requires pharmaceutical companies to provide details of biosimilar deals to the Federal Trade Commission for antitrust scrutiny.
One in 10 drugs sold in developing countries is fake or substandard, leading to tens of thousands of deaths with many of them of African children given ineffective treatments for pneumonia and malaria, health officials said.
Endo International Plc said two units filed a lawsuit accusing the U.S. Food and Drug Administration of ignoring key components of a law passed after a deadly 2012 meningitis outbreak linked to a compounding pharmacy.
A federal prosecutor told jurors that a Massachusetts pharmacist gambled with patients’ lives by making drugs in unsafe ways that led to a deadly 2012 fungal meningitis outbreak, but a defense lawyer said he was not a murderer.
India’s plan to bring in marketing rules to curb unethical promotional practices in the country’s drug industry faces an indefinite delay after it hit a legal roadblock, marking a setback for public health groups.
More than 400 people – including doctors and nurses – have been charged with defrauding Medicare and other federal healthcare programs of $1.3 billion, with many accused of illegally distributing opioids and other narcotics, the Justice Department said.
The pharmaceutical and healthcare industry is continuing to grow in complexity, impacted by factors such as industry regulations, the rise in digital technologies and changing business models. Most importantly, digitization has transformed everything – from creating brand value to meeting customers’ shifting expectations. As a result, pharmaceutical and healthcare organizations must focus their strategies to play a critical, central role in this digital transformation and revolution.